Projects per year
Dr. Li Fangfei graduated from Ocean University of China with a bachelor's degree in Chemistry in 2007. Following two years of master education in Ocean University, she started her PhD study in Australia under China Scholarship Council (CSC) scholarship in 2009. Dr. Li obtained her PhD degree in Chemistry from University of New South Wales in Australia in 2013. After postdoctoral training at Institute of Microbiology, Chinese Academy of Science in Beijing, she joined school of Chinese Medicine at Hong Kong Baptist University as a postdoctoral fellow in 2015, and then served as a research assistant professor since 2016. In 2021, Dr. Li was appointed as a tenure-track assistant professor.
novel anti-cancer therapies and targeted drug delivery.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
PhD, UNSW Sydney
Award Date: 31 Dec 2013
- 1 Similar Scholars
Collaborations and top research areas from the last five years
Dive into details
Select a country/territory to view shared publications and projects
Osteosarcoma-specific delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in a patient-derived xenograft model
1/01/19 → 31/12/22
Project: Research project
Dai, H., Abdullah, R., Wu, X., Li, F., Ma, Y., Lu, A. & Zhang, G., 16 May 2022, In: Frontiers in Cell and Developmental Biology. 10, 855474.
Research output: Contribution to journal › Review article › peer-reviewOpen Access3 Citations (Scopus)
Poly (ADP-ribose) polymerase 1 (PARP1) inhibition promotes pulmonary metastasis of osteosarcoma by boosting ezrin phosphorylationLi, F., Wu, X., Fu, X., Liu, J., Song, W., Xiao, G. G., Lu, A. & Zhang, G., Jan 2022, In: International Journal of Biological Sciences. 18, 3, p. 1238-1253 16 p.
Research output: Contribution to journal › Journal article › peer-reviewOpen Access2 Citations (Scopus)
Targeting 11β-HSD1 in osteoblasts reduces fat mass and prevents bone loss in mice with high-fat diet-induced obesity (abstract)Zhong, C., Li, N., Li, D., Wang, S., Zhang, H., Sun, M., Wang, Z., Xie, D., Wu, X., Li, F., Yu, S., Ma, Y., Dai, H., Amu, G., Lyu, A., Ren, F., Liu, J. & Zhang, G., Feb 2022, In: Journal of Bone and Mineral Research. 37, Suppl 1, p. 105 1 p.
Research output: Contribution to journal › Conference article › peer-review
Exosomal transfer of osteoclast-derived miRNAs to chondrocytes contributes to osteoarthritis progressionLiu, J., Wu, X., Lu, J., Huang, G., Dang, L., Zhang, H., Zhong, C., Zhang, Z., Li, D., Li, F., Liang, C., Yu, Y., Zhang, B. T., Chen, L., Lu, A. & Zhang, G., Apr 2021, In: Nature Aging. 1, 4, p. 368–384 17 p.
Research output: Contribution to journal › Journal article › peer-review23 Citations (Scopus)
Ni, S., Zhuo, Z., Pan, Y., Yu, Y., Li, F., Liu, J., Wang, L., Wu, X., Li, D., Wan, Y., Zhang, L., Yang, Z., Zhang, B-T., Lu, A. & Zhang, G., 3 Mar 2021, In: ACS applied materials & interfaces. 13, 8, p. 9500-9519 20 p.
Research output: Contribution to journal › Review article › peer-reviewOpen AccessFile186 Citations (Scopus)251 Downloads (Pure)
LI, Fangfei (Recipient) & LIU, Jin (Recipient), 23 May 2017
LI, Fangfei (Recipient), 2022
Hong Kong Traditional Chinese Medicine Pharmacology, Hong Kong Pharmacologists and Toxicologists Club, Hong Kong Science Park "University of Medicine Valley" Innovation Group Annual Conference (External organisation)
Fangfei LI (Chairman)2022
Activity: Membership › Membership of societies
Guangdong‐Hong Kong Macao Greater Bay Area International Research Platform for Aptamer‐Based Translational Medicine and Drug Discovery (External organisation)
Yuanyuan YU (Committee/panel/advisory board member), Aiping LYU (Director/non-executive director), Ge ZHANG (Director/non-executive director), Jin LIU (Working group member), Fangfei LI (Working group member) & Yuan MA (Working group member)2017 → …
Activity: Membership › Membership of board/committee/council